Stock listing

Sutro Biopharma, Inc.

Selected listing: STRO · NASDAQ · USD · US

Sutro Biopharma, Inc. (NASDAQ:STRO), Health Technology. Latest release Sep 29, 2026: Sutro Biopharma Appoints Lucas Donigian as Senior Vice President…

STRO:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:STRO
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. is a publicly traded company in the American market, listed under the ticker STRO. Sutro focuses on developing innovative therapeutics for cancer treatment using its proprietary technology platform.

Latest news from Sutro Biopharma, Inc.

Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development

September 29, 2026

Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development

September 28, 2026

Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

August 12, 2026

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

May 14, 2026

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

April 19, 2026

All Sutro Biopharma, Inc. news →

Research Sutro Biopharma, Inc.

Sutro Biopharma, Inc. company profile

View the public company page for Sutro Biopharma, Inc. on 6ix.

Sutro Biopharma, Inc. news

Read company news and market updates connected to Sutro Biopharma, Inc..

Sutro Biopharma, Inc. investor events

Find investor webinars, events, and replay context for Sutro Biopharma, Inc..